CClinicalTrials.gg
CompletedNCT01107314Updated Jan 17, 2018

Vasopressin Deficiency in Hemorrhagic Shock

An observational study in Body Response to Trauma, sponsored by The University of Texas Health Science Center at San Antonio. Completed at 1 site in United States. Open to participants aged 18 Years to 98 Years. Per ClinicalTrials.gov, last updated 2018-01-17.

Sponsored by The University of Texas Health Science Center at San Antonio · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
81
Ages
18 Years to 98 Years
Sex
All
01

Study summary

In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.

Read the detailed description

This is a prospective observational study. The only research-driven procedure will be the removal of blood samples at designated time points(total blood removed 48 cc per patient). Hemodynamic, fluid infusion and agitation/pain data (RAMSEY Score) will prospectively be collected for research purposes. We will collect data from a convenience sample of patients (when research staff is available) over a one year period.

02

Conditions studied

  • Body Response to Trauma
03

In context

Diabetes Insipidus, Neurogenic

24 studies on the registry are indexed under Diabetes Insipidus, Neurogenic; 12 are open to participants now.

Browse Diabetes Insipidus, Neurogenic studies →

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 435 studies on the registry; 88 are open to participants now.

Of its 62 completed or terminated interventional studies of FDA-regulated products, 31 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 98 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

observational study - trauma patients admitted to University Hospital

Inclusion criteria

  • Patient is a male or female patient presumed to be at least 18 years of age;
  • Patient has a reported or actual systolic blood pressure \< 90 mmHg within 1 hour of arrival to the Emergency Room;
  • Patient has clinical evidence of acute traumatic injury;

Exclusion criteria

Exclusion Criteria:

  • Patient is asystolic or requires CPR prior to arrival;
  • Patient was transferred from an outside facility
  • Patient known to be pregnant
  • Patient known to be prisoner
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
81 participants (actual)

Groups and cohorts

  • trauma patient

    SBP less than 90mmHg

    Other: Phlebotomy

Interventions

  • OtherPhlebotomy

    Blood draws (total 48 cc blood)

06

Study locations

1 site
  • UTHSCSA
    San Antonio, Texas 78229-3900, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01107314
Lead sponsor
The University of Texas Health Science Center at San Antonio
Responsible party
Sponsor
First posted
Apr 20, 2010
Start date
Feb 2010
Primary completion
Apr 30, 2011
Completion
Apr 30, 2011
Last update
Jan 17, 2018

Study contacts

Stephen M Cohn, MD
principal investigator · The University of Texas Health Science Center at San Antonio

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion